Gilead Sciences Inc. Canadian Depositary Receipt (GIS0)
FSX
Closed
Oct 9, 2026
Day's Range
18.3052 wk Range
14.40Overview - GIS0 - Gilead Sciences Inc. Canadian Depositary Receipt
Key Statistics
Valuation
Enterprise Value
264.69B
P/E (Trailing)
‪17.05‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪5.05‬
Price / Book
‪27.43‬
EV / EBITDA
‪20.69‬
Profitability
Gross Margin
‪79.76%‬
Profit Margin
‪-10.63%‬
Operating Margin
‪33.67%‬
Return on Assets
‪14.08%‬
Return on Equity
‪-20.68%‬
Ownership
Shares Outstanding
1.24B
Float
14.90B
Price stats
Beta
‪0.35‬
50-Day Avg
‪17.54‬
200-Day Avg
‪17.06‬
Dividends
Payout Ratio
‪43.24%‬
Frequency
Quarterly
Market Cap - GIS0 - Gilead Sciences Inc. Canadian Depositary Receipt
Peers - GIS0 - Gilead Sciences Inc. Canadian Depositary Receipt
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
- GIS0FSXGilead Sciences Inc. Canadian Depositary Receipt154.09BMarket Cap+25.81%52-week change17.05P/E (Trailing)‪-10.63%‬Profit Margin
- LLYFSXEli Lilly and Company910.25BMarket Cap+29.50%52-week change38.89P/E (Trailing)‪33.52%‬Profit Margin
- LLY0FSXEli Lilly CDR836.52BMarket Cap+33.20%52-week change36.06P/E (Trailing)‪33.52%‬Profit Margin
- JNJFSXJohnson & Johnson574.39BMarket Cap+35.37%52-week change31.44P/E (Trailing)‪21.48%‬Profit Margin
- JNJ0FSXJohnson & Johnson CDR525.52BMarket Cap+34.43%52-week change28.65P/E (Trailing)‪21.48%‬Profit Margin
- 4ABFSXAbbVie Inc.432.59BMarket Cap+18.10%52-week change79.44P/E (Trailing)‪9.80%‬Profit Margin
- 4AB0FSXAbbVie Inc. CDR360.66BMarket Cap+15.74%52-week change65.45P/E (Trailing)‪9.80%‬Profit Margin
Profile Summary - GIS0 - Gilead Sciences Inc. Canadian Depositary Receipt
About
Gilead Sciences Inc. Canadian Depositary Receipt is a Canadian-listed security that provides exposure to Gilead Sciences Inc., a global biopharmaceutical company headquartered in Foster City, California. Through this Canadian Depositary Receipt structure, investors can access the economic performance of Gilead…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
